JP2023504773A5 - - Google Patents
Info
- Publication number
- JP2023504773A5 JP2023504773A5 JP2022525579A JP2022525579A JP2023504773A5 JP 2023504773 A5 JP2023504773 A5 JP 2023504773A5 JP 2022525579 A JP2022525579 A JP 2022525579A JP 2022525579 A JP2022525579 A JP 2022525579A JP 2023504773 A5 JP2023504773 A5 JP 2023504773A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- acid sequence
- nucleic acid
- adeno
- capsid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19206603 | 2019-10-31 | ||
| EP19206603.3 | 2019-10-31 | ||
| PCT/EP2020/080704 WO2021084133A1 (en) | 2019-10-31 | 2020-11-02 | Aav vector variants for ocular gene delivery |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023504773A JP2023504773A (ja) | 2023-02-07 |
| JP2023504773A5 true JP2023504773A5 (cg-RX-API-DMAC7.html) | 2023-11-10 |
| JP7791546B2 JP7791546B2 (ja) | 2025-12-24 |
Family
ID=68426130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022525579A Active JP7791546B2 (ja) | 2019-10-31 | 2020-11-02 | 眼遺伝子送達のためのaavベクター変異体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12509705B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4051694B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7791546B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220093163A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114729009A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020373326A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3157464A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL291240A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021084133A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4349852A4 (en) * | 2021-05-28 | 2025-09-03 | Shanghai Regenelead Therapies Co Ltd | RECOMBINANT ADENO-ASSOCIATED VIRUS HAVING A VARIANT CAPSID, AND ITS APPLICATION |
| KR20240095539A (ko) | 2021-10-08 | 2024-06-25 | 디노 테라퓨틱스, 인코포레이티드 | 캡시드 변이체 및 이의 사용 방법 |
| KR20240152351A (ko) * | 2022-02-17 | 2024-10-21 | 스카이라인 테라퓨틱스 리미티드 | 변형된 aav 캡시드 폴리펩티드를 갖는 재조합 아데노-연관 바이러스 |
| JP2026509271A (ja) | 2023-03-10 | 2026-03-17 | ダイノ セラピューティクス,インコーポレーテッド | カプシドポリペプチドおよびその使用方法 |
| CN121219325A (zh) * | 2023-05-23 | 2025-12-26 | 北京因诺惟康医药科技有限公司 | 一种腺相关病毒衣壳蛋白、包含其的腺相关病毒、载体及应用 |
| KR20260082361A (ko) | 2023-08-31 | 2026-06-04 | 디노 테라퓨틱스, 인코포레이티드 | 캡시드 폴리펩타이드 및 이의 사용 방법 |
| WO2025051292A1 (zh) * | 2024-01-16 | 2025-03-13 | 广州译码基因科技有限公司 | 提高aav病毒对眼组织感染能力的衣壳蛋白突变体及其应用 |
| CN118440161B (zh) * | 2024-01-16 | 2025-02-25 | 沈阳兴齐眼药股份有限公司 | 提高aav病毒视网膜穿透能力的衣壳蛋白突变体及其应用 |
| TW202545971A (zh) | 2024-02-08 | 2025-12-01 | 美商戴諾治療公司 | 殼體多肽及其使用方法 |
| US20260042803A1 (en) * | 2024-08-09 | 2026-02-12 | Revvity Gene Delivery Gmbh | Variant aav capsid polypeptides targeting the eye |
| WO2026064442A2 (en) | 2024-09-18 | 2026-03-26 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
| WO2026122963A1 (en) | 2024-12-06 | 2026-06-11 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
| WO2026123017A1 (en) * | 2024-12-06 | 2026-06-11 | General Medicines Inc. | Compositions and methods for improved adeno-associated viral gene therapy |
| WO2026160681A1 (ko) * | 2025-01-24 | 2026-07-30 | 연세대학교 산학협력단 | 망막 세포 표적화 아데노-관련 바이러스 변이체 kap 및 그의 용도 |
| WO2026160680A1 (ko) * | 2025-01-24 | 2026-07-30 | 연세대학교 산학협력단 | 망막 세포 표적화 아데노-관련 바이러스 변이체 adn 및 그의 용도 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284746A (en) | 1990-02-08 | 1994-02-08 | Zymogenetics, Inc. | Methods of producing hybrid G protein-coupled receptors |
| WO1997005252A2 (en) | 1995-07-26 | 1997-02-13 | Nps Pharmaceuticals, Inc. | Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| US20040248202A1 (en) | 1998-09-03 | 2004-12-09 | Wisconsin Alumni Research Foundation | Bacteriorhodopsin/G protein-coupled receptor chimeras |
| US9284363B2 (en) | 2006-07-26 | 2016-03-15 | Case Western Reserve University | System and method for controlling G-protein coupled receptor pathways |
| EP2294208B1 (en) | 2008-05-29 | 2013-05-08 | The Board of Trustees of The Leland Stanford Junior University | Cell line, system and method for optical control of secondary messengers |
| GB2498325B (en) | 2010-10-15 | 2018-05-02 | Eos Neuroscience Inc | Engineered human GRM6 enhancer sequence for use in eye therapies |
| DK3693025T3 (da) * | 2011-04-22 | 2022-01-10 | Univ California | Adenoassocierede virus-virioner med variant capsid og fremgangsmåder til anvendelse heraf |
| CA2840458C (en) | 2011-06-24 | 2020-09-22 | Haag-Streit Medtech Ag | Light-sensitive chimeric gpcr protein |
| WO2013003557A1 (en) | 2011-06-28 | 2013-01-03 | University Of Rochester | Photoactivatable receptors and their uses |
| US20140087463A1 (en) | 2012-09-25 | 2014-03-27 | The Washington University | Optical control of cell signaling |
| RU2664471C2 (ru) | 2013-07-26 | 2018-08-17 | Юниверсити Оф Айова Рисерч Фаундейшн | Способы и композиции для лечения болезней мозга |
| KR102234695B1 (ko) | 2014-02-06 | 2021-04-02 | 젠자임 코포레이션 | 황반 변성을 치료하고 예방하기 위한 조성물 및 방법 |
| WO2015126972A1 (en) | 2014-02-21 | 2015-08-27 | University Of Florida Research Foundation, Inc. | Methods and compositions for gene delivery to on bipolar cells |
| GB201403260D0 (en) | 2014-02-25 | 2014-04-09 | Univ Manchester | Treatment of retinal degeneration using gene therapy |
| US10307492B2 (en) | 2014-03-11 | 2019-06-04 | Wayne State University | Modified MGLUR6 promoter and methods of use |
| CA2977355A1 (en) * | 2015-02-20 | 2016-08-25 | University Of Iowa Research Foundation | Methods and compositions for treating genetic eye diseases |
| FI3265178T3 (fi) | 2015-03-02 | 2026-08-03 | Adverum Biotechnologies Inc | Koostumuksia ja menetelmiä polynukleotidien viemiseksi intravitreaalisesti retinaalisiin tappisoluihin |
| WO2016149664A1 (en) | 2015-03-18 | 2016-09-22 | University Of Florida Research Foundation, Inc. | Methods and compositions for restoration of cone function in bcm |
| CN105154470A (zh) | 2015-07-22 | 2015-12-16 | 华东师范大学 | 一种高效筛查g蛋白-偶联受体表达的融合基因构建方法 |
| WO2017197355A2 (en) | 2016-05-13 | 2017-11-16 | 4D Molecular Therapeutics Inc. | Adeno-associated virus variant capsids and methods of use thereof |
| CN109640949B (zh) | 2016-07-29 | 2022-11-25 | 加利福尼亚大学董事会 | 具有变异衣壳的腺相关病毒病毒体和其使用方法 |
| EP3508212B1 (en) | 2016-09-02 | 2025-10-22 | Keio University | Rhodopsin gene therapy for regenerating visual function or for preventing deterioration in visual function |
| US10376265B2 (en) | 2017-01-30 | 2019-08-13 | Ethicon Llc | Non-magnetic fragmentable tissue compression devices |
| KR20250023600A (ko) * | 2017-06-30 | 2025-02-18 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 변이체 캡시드를 보유한 아데노-부속 바이러스 비리온 및 이의 사용 방법 |
| AU2018350700B2 (en) * | 2017-10-16 | 2025-04-24 | VeonGen Therapeutics GmbH | AAV vectors |
| JP7029160B2 (ja) | 2017-11-24 | 2022-03-03 | 公立大学法人大阪 | 新規な光受容タンパク質 |
| US11766489B2 (en) | 2017-11-27 | 2023-09-26 | 4D Molecular Therapeutics, Inc. | Adeno-associated virus variant capsids and use for inhibiting angiogenesis |
| CA3127535A1 (en) | 2019-01-18 | 2020-07-23 | Restore Vision Inc. | Preventing, and suppressing progression of, retinal disease, improving visual cognitive behavioral function, and strengthening visual function |
| AU2020385619B2 (en) | 2019-11-18 | 2023-06-01 | Universität Bern | On-bipolar cell-specific promoters for ocular gene delivery |
| KR20220111294A (ko) | 2019-11-29 | 2022-08-09 | 유니버시태트 베른 | 키메라 옵신 gpcr 단백질 |
-
2020
- 2020-11-02 CN CN202080074852.9A patent/CN114729009A/zh active Pending
- 2020-11-02 WO PCT/EP2020/080704 patent/WO2021084133A1/en not_active Ceased
- 2020-11-02 CA CA3157464A patent/CA3157464A1/en active Pending
- 2020-11-02 JP JP2022525579A patent/JP7791546B2/ja active Active
- 2020-11-02 US US17/755,434 patent/US12509705B2/en active Active
- 2020-11-02 EP EP20841660.2A patent/EP4051694B1/en active Active
- 2020-11-02 KR KR1020227018274A patent/KR20220093163A/ko not_active Ceased
- 2020-11-02 AU AU2020373326A patent/AU2020373326A1/en not_active Abandoned
-
2022
- 2022-03-09 IL IL291240A patent/IL291240A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7860176B2 (ja) | 変異aav、及び、細胞、臓器並びに組織への遺伝子導入のための組成物、方法並びに使用法 | |
| JP7791546B2 (ja) | 眼遺伝子送達のためのaavベクター変異体 | |
| KR102298579B1 (ko) | 캡시드-변형된 raav3 벡터 조성물, 및 인간 간암의 유전자 요법에서의 용도 | |
| US20240091383A1 (en) | Synergistic effect of smn1 and mir-23a in treating spinal muscular atrophy | |
| KR20150005521A (ko) | 세포, 기관 및 조직으로의 유전자 전이를 위한 aav 벡터 조성물 및 방법 | |
| RU2020137429A (ru) | Лечение пигментного ретинита | |
| JP2022531861A5 (cg-RX-API-DMAC7.html) | ||
| CN104087591A (zh) | 用于基因治疗的修饰的因子viii和因子ix基因和载体 | |
| US12359219B2 (en) | Transgene cassettes designed to express a human MECP2 gene | |
| AU2019360937A1 (en) | Expression vectors for large-scale production of rAAV in the baculovirus/Sf9 system | |
| JP2022512589A5 (cg-RX-API-DMAC7.html) | ||
| WO2024240113A1 (zh) | 一种腺相关病毒衣壳蛋白、包含其的腺相关病毒、载体及应用 | |
| CN114276419B (zh) | 肌肉高亲和性的新型腺相关病毒衣壳蛋白及其应用 | |
| JP2024543994A (ja) | 硝子体内投与用の機能性aavカプシド | |
| JP2023551254A5 (cg-RX-API-DMAC7.html) | ||
| CN117003833A (zh) | 肝脏特异性的腺相关病毒血清型及应用 | |
| WO2024138833A1 (zh) | 一种改造的重组凝血因子viii及其应用 | |
| CN118613590A (zh) | 用于玻璃体内施用的功能性aav衣壳 | |
| US20240076691A1 (en) | Codon-optimized nucleic acid encoding the fix protein | |
| RU2716999C1 (ru) | Способ получения рекомбинантных аденоассоциированных вирусов для использования в генной терапии | |
| RU2837753C2 (ru) | Вариант aav, композиции и способы, в которых он используется, а также способы его применения для переноса генов в клетки, органы и ткани | |
| WO2025065890A1 (zh) | 一种重组腺相关病毒颗粒、重组腺相关病毒载体系统及其应用 | |
| HK40109360A (en) | Functional aav capsids for intravitreal administration | |
| WO2025193808A1 (en) | Cns-specific gene replacement therapy for genetic forms of als/ftd | |
| HK40109258A (en) | Codon-optimized nucleic acid encoding the fix protein |